IVACAFTOR and INFECTION

Overview

INFECTION is the #4 most commonly reported adverse reaction for IVACAFTOR, manufactured by Vertex Pharmaceuticals Incorporated. There are 249 FDA adverse event reports linking IVACAFTOR to INFECTION. This represents approximately 2.7% of all 9,200 adverse event reports for this drug.

Patients taking IVACAFTOR who experience infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INFECTION is a less commonly reported adverse event for IVACAFTOR, but still significant enough to appear in the safety profile.

Other Side Effects of IVACAFTOR

In addition to infection, the following adverse reactions have been reported for IVACAFTOR:

• HOSPITALISATION — 1,286 reports
• INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS — 601 reports
• PNEUMONIA — 262 reports
• MALAISE — 247 reports
• LOWER RESPIRATORY TRACT INFECTION — 242 reports
• DEATH — 224 reports
• COUGH — 219 reports
• CYSTIC FIBROSIS — 211 reports
• HEADACHE — 194 reports
• NASOPHARYNGITIS — 168 reports

Other Drugs Associated with INFECTION

The following drugs have also been linked to infection in FDA adverse event reports:

Does IVACAFTOR cause INFECTION?

INFECTION has been reported as an adverse event in 249 FDA reports for IVACAFTOR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INFECTION with IVACAFTOR?

INFECTION accounts for approximately 2.7% of all adverse event reports for IVACAFTOR, making it a notable side effect.

What should I do if I experience INFECTION while taking IVACAFTOR?

If you experience infection while taking IVACAFTOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages